$2.180
-0.096 (-4.39%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RNAZ por análisis de gráficos similares
Alphio's RNAZ stock price prediction model matches the current Transcode Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.13 (-2.18%). The 1-week path is $2.14 (-1.73%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Transcode Therapeutics Inc?
Transcode Therapeutics Inc (RNAZ) is not a good buy right now due to its extremely low RSI of 6.667, indicating it is oversold, and a staggering year-to-date change of -70.54%, suggesting a significant decline in value. The forward P/E ratio is 0, indicating no expected earnings, and the stock has a current price of 2.18, which is far below its historical SMA of 7.604. The main risk is the negative net income, which reached -19,510,296 in Q1 2026, reflecting ongoing financial struggles.
RNAZ cerró en $2.18 el Friday, tras bajar -4.39%
Transcode Therapeutics Inc (RNAZ) last closed at $2.18, losing -4.39%. These facts feed the 1-day and 1-week RNAZ price prediction above.
Factores de la previsión
Los factores de la previsión de Transcode Therapeutics Inc (RNAZ) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RNAZ, ordenadas por similitud.
Análisis de estacionalidad de RNAZ
Historically the probability of a positive August return for RNAZ is 0.00%. February offers the highest probability of a positive month at 60.34%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RNAZ
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $7.37 | $9.12 | $9.36 | +318.31% |
| Sep 2026 | $11.96 | $12.00 | $12.62 | +450.58% |
| Oct 2026 | $9.13 | $10.52 | $12.41 | +382.69% |
| Nov 2026 | $11.60 | $11.70 | $13.54 | +436.50% |
| Dec 2026 | $10.48 | $12.00 | $12.58 | +450.58% |
En 2026, se proyecta que Transcode Therapeutics Inc (RNAZ) oscile entre $7.37 y $13.54.
Previsión mensual de Transcode Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Transcode Therapeutics Inc promedie $9.12, con un mínimo de $7.37 y un máximo de $9.36.
En Sep de 2026, se proyecta que Transcode Therapeutics Inc promedie $12.00, con un mínimo de $11.96 y un máximo de $12.62.
En Oct de 2026, se proyecta que Transcode Therapeutics Inc promedie $10.52, con un mínimo de $9.13 y un máximo de $12.41.
En Nov de 2026, se proyecta que Transcode Therapeutics Inc promedie $11.70, con un mínimo de $11.60 y un máximo de $13.54.
En Dec de 2026, se proyecta que Transcode Therapeutics Inc promedie $12.00, con un mínimo de $10.48 y un máximo de $12.58.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.